Risk of VTE 6-Fold Higher in CLL/MBL Than in General Population
Patients with chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis have an increased risk of venous thromboembolism, a study suggests.
Patients with chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis have an increased risk of venous thromboembolism, a study suggests.
Researchers sought to determine whether the addition of IPC to thromboprophylaxis for prevention of VTE is based on sound evidence.
Regardless of vaccination status, adults hospitalized for COVID-19 infection are at increased risk for acute thromboembolism
Researchers sought to determine whether patients with cancer were aware of their risk of developing cancer-associated venous thromboembolism.
Improvement seen with electronic alert-triggered, patient-centered education bundle intervention or nurse feedback intervention.
Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery.
Researchers sought to determine patters related to age and sex in outcomes for patients with CVT.
Researchers assessed nationwide trends of venous thromboembolism-related hospitalizations among patients with inflammatory bowel disease.
Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events.
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.